• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状患者的主动监测文化方案作为控制多药耐药革兰氏阴性菌的策略:需要考虑哪些因素?

Active surveillance culture program in asymptomatic patients as a strategy to control multidrug-resistant gram-negative organisms: What should be considered?

机构信息

Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.

Division of Infectious Diseases, Department of Medicine, Thammasat University Hospital, Pratumthani, Thailand.

出版信息

J Formos Med Assoc. 2020 Nov;119(11):1581-1585. doi: 10.1016/j.jfma.2019.08.015. Epub 2019 Aug 27.

DOI:10.1016/j.jfma.2019.08.015
PMID:31471223
Abstract

The increasing burden of multidrug-resistant gram-negative bacilli (MDR-GNB) infection has highlighted the urgent requirement for efficient prevention and control strategies. A routine active surveillance culture (ASC) program of asymptomatic carriers as part of an infection prevention strategy for MDR-GNB still has some controversy. An ASC program for colonized patients may be beneficial depending on the targeted population, level of endemicity, the species of pathogen, and the combination of multifaceted strategies. Multimodal infection control and prevention strategies are crucial for implementation in resources-limited settings. After discovering the culprit, it is a challenge to control MDR-GNB by containment or eradication and prevent cross-transmission. An ASC program should consider both the local epidemiology and cost-effectiveness based on the available resources in endemic MDR-GNB areas in the Asia-Pacific region.

摘要

多重耐药革兰氏阴性杆菌(MDR-GNB)感染负担不断增加,这凸显了迫切需要有效的预防和控制策略。无症状携带者的常规主动监测培养(ASC)作为 MDR-GNB 感染预防策略的一部分,仍然存在一些争议。对于定植患者的 ASC 方案可能是有益的,具体取决于目标人群、流行程度、病原体种类以及多方面策略的结合。在资源有限的情况下,实施多种模式的感染控制和预防策略至关重要。发现罪魁祸首后,通过隔离或根除来控制 MDR-GNB 并防止交叉传播是一项挑战。ASC 方案应根据亚太地区 MDR-GNB 流行地区的当地流行病学和资源利用情况,考虑成本效益。

相似文献

1
Active surveillance culture program in asymptomatic patients as a strategy to control multidrug-resistant gram-negative organisms: What should be considered?无症状患者的主动监测文化方案作为控制多药耐药革兰氏阴性菌的策略:需要考虑哪些因素?
J Formos Med Assoc. 2020 Nov;119(11):1581-1585. doi: 10.1016/j.jfma.2019.08.015. Epub 2019 Aug 27.
2
The Increasing Challenge of Multidrug-Resistant Gram-Negative Bacilli: Results of a 5-Year Active Surveillance Program in a Neonatal Intensive Care Unit.多重耐药革兰氏阴性杆菌带来的挑战日益增加:新生儿重症监护病房一项为期5年的主动监测项目结果
Medicine (Baltimore). 2016 Mar;95(10):e3016. doi: 10.1097/MD.0000000000003016.
3
High Rate of Multidrug-Resistant Gram-Negative Bacilli Carriage and Infection in Hospitalized Returning Travelers: A Cross-Sectional Cohort Study.住院归国旅行者中携带和感染耐多药革兰氏阴性杆菌的比率较高:一项横断面队列研究。
J Travel Med. 2015 Sep-Oct;22(5):292-9. doi: 10.1111/jtm.12211. Epub 2015 May 22.
4
Multidrug-Resistant Gram-Negative Bacteria: Infection Prevention and Control Update.多重耐药革兰氏阴性菌:感染预防与控制更新。
Infect Dis Clin North Am. 2021 Dec;35(4):969-994. doi: 10.1016/j.idc.2021.08.001.
5
Variation in definitions and isolation procedures for multidrug-resistant Gram-negative bacteria: a survey of the Society for Healthcare Epidemiology of America Research Network.耐多药革兰氏阴性菌定义与分离程序的差异:美国医疗保健流行病学学会研究网络的一项调查
Infect Control Hosp Epidemiol. 2014 Apr;35(4):362-6. doi: 10.1086/675600.
6
ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.ESCMID-EUCIC 临床指南:多重耐药革兰氏阴性菌携带者的去定植化。
Clin Microbiol Infect. 2019 Jul;25(7):807-817. doi: 10.1016/j.cmi.2019.01.005. Epub 2019 Jan 29.
7
Predicting Multidrug-Resistant Gram-Negative Bacterial Colonization and Associated Infection on Hospital Admission.预测住院时多重耐药革兰氏阴性菌定植和相关感染。
Infect Control Hosp Epidemiol. 2017 Oct;38(10):1216-1225. doi: 10.1017/ice.2017.178. Epub 2017 Sep 5.
8
High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.墨西哥尤卡坦州一家三级医院重症监护病房中革兰氏阴性杆菌的抗生素耐药率很高。
Medicina (Kaunas). 2019 Sep 13;55(9):588. doi: 10.3390/medicina55090588.
9
Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria.治疗多重耐药革兰氏阴性菌感染的研究性药物。
Expert Opin Investig Drugs. 2018 Apr;27(4):325-338. doi: 10.1080/13543784.2018.1460354. Epub 2018 Apr 10.
10
Active surveillance for asymptomatic colonization with multidrug-resistant gram negative bacilli among injured service members--a three year evaluation.对受伤军人中耐多药革兰氏阴性杆菌无症状定植的主动监测——一项为期三年的评估
MSMR. 2013 Aug;20(8):17-22.

引用本文的文献

1
Outbreaks in the Neonatal Intensive Care Unit: Description and Management.新生儿重症监护病房的疫情:描述与管理
Trop Med Infect Dis. 2024 Sep 12;9(9):212. doi: 10.3390/tropicalmed9090212.
2
Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak.基于头孢地尔的方案治疗不动杆菌NDM-1暴发感染
Antibiotics (Basel). 2024 Aug 15;13(8):770. doi: 10.3390/antibiotics13080770.
3
Synergy between infection control and antimicrobial stewardship programs to control carbapenem-resistant Enterobacterales.感染控制与抗菌药物管理计划之间的协同作用以控制耐碳青霉烯类肠杆菌科细菌。
Antimicrob Steward Healthc Epidemiol. 2023 Sep 26;3(1):e162. doi: 10.1017/ash.2023.439. eCollection 2023.
4
Gastrointestinal Colonization of Carbapenem-Resistant : What Is the Implication for Infection Control?耐碳青霉烯类药物的胃肠道定植:对感染控制有何影响?
Antibiotics (Basel). 2022 Sep 22;11(10):1297. doi: 10.3390/antibiotics11101297.
5
Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study.碳青霉烯类耐药革兰氏阴性菌的主动监测以指导抗生素治疗:一项单中心前瞻性观察研究。
Antimicrob Resist Infect Control. 2022 Jun 22;11(1):89. doi: 10.1186/s13756-022-01103-0.
6
Prolonged carriage of ESBL-producing enterobacterales and potential cross-transmission among residents in geriatric long-term care facilities.产超广谱β-内酰胺酶肠杆菌科细菌的长时间携带和老年长期护理机构居民之间的潜在交叉传播。
Sci Rep. 2021 Nov 3;11(1):21607. doi: 10.1038/s41598-021-01190-w.